• Financial performance: In Q4, standalone underlying volume growth reached 8% and underlying sales grew 10%, though adjusted net profit missed street estimates following an exceptional loss of ₹93 crore.
• Inflation and pricing: To offset 7% to 9% raw material inflation driven by elevated crude prices, the company executed calibrated price increases of 4% to 5% alongside cost optimizations to protect EBITDA margins.
• Home insecticides growth: The segment remains a key driver of top-line and bottom-line performance with strong margin profiles, supported by product relaunches with new molecules and the introduction of authorized incense sticks.
• International business recovery: Indonesia's revenue and volume grew 4% in Q4 with profit turnaround projected for next year, while Africa recorded its fifth consecutive quarter of strong top-line growth and tenth quarter of profit growth.